speb/financial-data huggingface dataset:
CTVA cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -717000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 6808000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 449000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 258000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 449000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 258000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 2229000000.00
CTVA income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 2248000000.00
CTVA income_statement (quarterly, 2025-06-30) — Normalized Income: 1449712860.31
CTVA cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 947000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -4000000.00
CTVA income_statement (quarterly, 2025-06-30) — Operating Income: 1832000000.00
CTVA income_statement (quarterly, 2025-06-30) — Operating Revenue: 6456000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 679879000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 873000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 1482000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -2644000000.00
CTVA income_statement (quarterly, 2025-06-30) — Other Gand A: 1156000000.00
CTVA income_statement (quarterly, 2025-06-30) — Other Income Expense: -7000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 8583000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 243000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1918000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 1918000000.00
CTVA income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 85000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Other Receivables: 1209000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 76000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Payables: 4313000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 7216000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Pension And Employee Benefit Expense: 9000000.00
CTVA income_statement (quarterly, 2025-06-30) — Pretax Income: 1804000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 35000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -56000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Raw Materials: 421000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Receivables: 8674000000.00
CTVA income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2792000000.00
CTVA income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 301000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -321000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -250000000.00
CTVA income_statement (quarterly, 2025-06-30) — Research And Development: 375000000.00
CTVA income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 79000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 1532000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
CTVA cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 17000000.00
CTVA income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1156000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Share Issued: 679879000.00
CTVA income_statement (quarterly, 2025-06-30) — Special Income Charges: -66000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 25909000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 6808000000.00
CTVA income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -21287139.69
CTVA income_statement (quarterly, 2025-06-30) — Tax Provision: 422000000.00
CTVA income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.23
CTVA balance_sheet (quarterly, 2025-06-30) — Total Assets: 41759000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 27596000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Total Debt: 3629000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 26151000000.00
CTVA income_statement (quarterly, 2025-06-30) — Total Expenses: 4624000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 15608000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 25755000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 6092000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 485000000.00
CTVA income_statement (quarterly, 2025-06-30) — Total Unusual Items: -91000000.00
CTVA income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -91000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Work In Process: 1961000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Working Capital: 6488000000.00
CTVA income_statement (quarterly, 2025-09-30) — +Operating Expense: 1244000000.00
CTVA income_statement (quarterly, 2025-09-30) — +Total Revenue: 2618000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 4337000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 6428000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -5431000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 27039000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -220000000.00
CTVA income_statement (quarterly, 2025-09-30) — Amortization: 162000000.00
CTVA income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 162000000.00
CTVA income_statement (quarterly, 2025-09-30) — Basic Average Shares: 678700000.00
CTVA income_statement (quarterly, 2025-09-30) — Basic EPS: -0.47
CTVA cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 2317000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -157000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -157000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 0.00
CTVA balance_sheet (quarterly, 2025-09-30) — Capital Stock: 7000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 2509000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 2586000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -122000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 367000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -157000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 198000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Cash From Discontinued Operating Activities: -5000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 479000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Change In Inventory: -979000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -442000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Change In Payable: 479000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 479000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Change In Receivables: 885000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -57000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Changes In Cash: 403000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Commercial Paper: 1772000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Common Stock: 7000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -122000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 25219000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -250000000.00
CTVA income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1644000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 2661000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Current Assets: 16438000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 0.00
CTVA balance_sheet (quarterly, 2025-09-30) — Current Debt: 2685000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2685000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 483000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 483000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 10420000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 137000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Deferred Tax: 137000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 300000000.00
CTVA income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 162000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 300000000.00
CTVA income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 162000000.00
CTVA income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 678700000.00
CTVA income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.47
CTVA income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -320000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 108000000.00
CTVA income_statement (quarterly, 2025-09-30) — EBIT: -324000000.00
CTVA income_statement (quarterly, 2025-09-30) — EBITDA: -24000000.00
CTVA income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: -1000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 17000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 2215000000.00
CTVA cash_flow (quarterly, 2025-09-30) — End Cash Position: 2737000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 367000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Finished Goods: 2318000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 36000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00
CTVA income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: 0.00
CTVA income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -45000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -2661000000.00
CTVA income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 731000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Goodwill: 10512000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 18940000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 6648000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Gross PPE: 9633000000.00
CTVA income_statement (quarterly, 2025-09-30) — Gross Profit: 974000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 254000000.00
CTVA income_statement (quarterly, 2025-09-30) — Interest Expense: 46000000.00
CTVA income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 46000000.00
CTVA income_statement (quarterly, 2025-09-30) — Interest Income: 29000000.00
CTVA income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 29000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Inventory: 5310000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Invested Capital: 29592000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -157000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 141000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 429000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 0.00
CTVA balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1688000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1688000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 429000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -781000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 141000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Minority Interest: 242000000.00
CTVA income_statement (quarterly, 2025-09-30) — Minority Interests: -2000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -250000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Net Debt: 1864000000.00
CTVA income_statement (quarterly, 2025-09-30) — Net Income: -320000000.00
CTVA income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -320000000.00
CTVA income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -308000000.00
CTVA income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: -10000000.00
CTVA income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -320000000.00
CTVA income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -310000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -308000000.00
CTVA income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -318000000.00
CTVA income_statement (quarterly, 2025-09-30) — Net Interest Income: -17000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 6000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 739000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -352000000.00
CTVA income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -17000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -5000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 0.00
CTVA balance_sheet (quarterly, 2025-09-30) — Net PPE: 4202000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 1000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 1091000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 6279000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 434000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 373000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 434000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 373000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 2215000000.00
CTVA income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 58000000.00
CTVA income_statement (quarterly, 2025-09-30) — Normalized Income: -241740540.54
CTVA cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 193000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 8000000.00
CTVA income_statement (quarterly, 2025-09-30) — Operating Income: -270000000.00
CTVA income_statement (quarterly, 2025-09-30) — Operating Revenue: 2618000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 676755000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 758000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 913000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -2661000000.00
CTVA income_statement (quarterly, 2025-09-30) — Other Gand A: 725000000.00
CTVA income_statement (quarterly, 2025-09-30) — Other Income Expense: -83000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 8428000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 118000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 2043000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 2041000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Other Receivables: 1248000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 77000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Payables: 4591000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 7252000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Pension And Employee Benefit Expense: 8000000.00
CTVA income_statement (quarterly, 2025-09-30) — Pretax Income: -370000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 5000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 0.00
CTVA balance_sheet (quarterly, 2025-09-30) — Raw Materials: 436000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Receivables: 7784000000.00
CTVA income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1506000000.00
CTVA income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 300000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -781000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -250000000.00
CTVA income_statement (quarterly, 2025-09-30) — Research And Development: 351000000.00
CTVA income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 37000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 834000000.00
CTVA income_statement (quarterly, 2025-09-30) — Salaries And Wages: 6000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 6000000.00
CTVA cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 1000000.00
CTVA income_statement (quarterly, 2025-09-30) — Selling General And Administration: 731000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Share Issued: 676755000.00
CTVA income_statement (quarterly, 2025-09-30) — Special Income Charges: -37000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 25219000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 6279000000.00
CTVA income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -13740540.54
CTVA income_statement (quarterly, 2025-09-30) — Tax Provision: -62000000.00
CTVA income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.17
CTVA balance_sheet (quarterly, 2025-09-30) — Total Assets: 42198000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 26907000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Total Debt: 4373000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 25461000000.00
CTVA income_statement (quarterly, 2025-09-30) — Total Expenses: 2888000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 16737000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 25760000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 6317000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 254000000.00
CTVA income_statement (quarterly, 2025-09-30) — Total Unusual Items: -82000000.00
CTVA income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -82000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Work In Process: 2556000000.00
CTVA balance_sheet (quarterly, 2025-09-30) — Working Capital: 6018000000.00
CTVA income_statement (annual, 2025-12-31) — +Operating Expense: 5610000000.00
CTVA income_statement (quarterly, 2025-12-31) — +Operating Expense: 1414000000.00
CTVA income_statement (annual, 2025-12-31) — +Total Revenue: 17401000000.00
CTVA income_statement (quarterly, 2025-12-31) — +Total Revenue: 3910000000.00
CTVA balance_sheet (annual, 2025-12-31) — Accounts Payable: 4398000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 4398000000.00
CTVA balance_sheet (annual, 2025-12-31) — Accounts Receivable: 5034000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 5034000000.00
CTVA balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -5331000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -5331000000.00
CTVA balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 27001000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 27001000000.00
CTVA balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -241000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -241000000.00
CTVA income_statement (annual, 2025-12-31) — Amortization: 644000000.00
CTVA income_statement (quarterly, 2025-12-31) — Amortization: 159000000.00
CTVA cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 644000000.00
CTVA cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 644000000.00
CTVA income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 644000000.00
CTVA income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 159000000.00
CTVA income_statement (annual, 2025-12-31) — Basic Average Shares: 680000000.00
CTVA income_statement (quarterly, 2025-12-31) — Basic Average Shares: 674700000.00
CTVA income_statement (annual, 2025-12-31) — Basic EPS: 1.60
CTVA income_statement (quarterly, 2025-12-31) — Basic EPS: -0.82
CTVA cash_flow (annual, 2025-12-31) — Beginning Cash Position: 3422000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 2737000000.00
CTVA balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 1867000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 1867000000.00
CTVA cash_flow (annual, 2025-12-31) — Capital Expenditure: -591000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -222000000.00
CTVA cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -591000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -222000000.00
CTVA balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 0.00
CTVA balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 0.00
CTVA balance_sheet (annual, 2025-12-31) — Capital Stock: 7000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Capital Stock: 7000000.00
CTVA balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 4521000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 4521000000.00
CTVA balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 4530000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 4530000000.00
CTVA cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -475000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -121000000.00
CTVA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1644000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2198000000.00
CTVA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -543000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -188000000.00
CTVA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 3457000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 4398000000.00
CTVA cash_flow (annual, 2025-12-31) — Cash From Discontinued Operating Activities: -51000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Cash From Discontinued Operating Activities: -23000000.00
CTVA cash_flow (annual, 2025-12-31) — Change In Account Payable: 231000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 108000000.00
CTVA cash_flow (annual, 2025-12-31) — Change In Inventory: -35000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Change In Inventory: -366000000.00
CTVA cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 606000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 3325000000.00
CTVA cash_flow (annual, 2025-12-31) — Change In Payable: 231000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Change In Payable: 108000000.00
CTVA cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 231000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 108000000.00
CTVA cash_flow (annual, 2025-12-31) — Change In Receivables: -261000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Change In Receivables: 1398000000.00
CTVA cash_flow (annual, 2025-12-31) — Change In Working Capital: 541000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 4465000000.00
CTVA cash_flow (annual, 2025-12-31) — Changes In Cash: 1219000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Changes In Cash: 1989000000.00
CTVA balance_sheet (annual, 2025-12-31) — Common Stock: 7000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Common Stock: 7000000.00
CTVA balance_sheet (annual, 2025-12-31) — Common Stock Equity: 24144000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 24144000000.00
CTVA cash_flow (annual, 2025-12-31) — Common Stock Payments: -1071000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -301000000.00
CTVA balance_sheet (annual, 2025-12-31) — Construction In Progress: 386000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 386000000.00
CTVA income_statement (annual, 2025-12-31) — Cost Of Revenue: 9172000000.00
CTVA income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2254000000.00
CTVA balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 3099000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 3099000000.00
CTVA balance_sheet (annual, 2025-12-31) — Current Assets: 17335000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Current Assets: 17335000000.00
CTVA balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 0.00
CTVA balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 0.00
CTVA balance_sheet (annual, 2025-12-31) — Current Debt: 894000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Current Debt: 894000000.00
CTVA balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 894000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 894000000.00
CTVA balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 3579000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 3579000000.00
CTVA balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 3579000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 3579000000.00
CTVA balance_sheet (annual, 2025-12-31) — Current Liabilities: 12125000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 12125000000.00
CTVA cash_flow (annual, 2025-12-31) — Deferred Income Tax: -41000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 31000000.00
CTVA cash_flow (annual, 2025-12-31) — Deferred Tax: -41000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Deferred Tax: 31000000.00
CTVA cash_flow (annual, 2025-12-31) — Depreciation: 559000000.00
CTVA cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1203000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 306000000.00
CTVA income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 644000000.00
CTVA income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 159000000.00
CTVA cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1203000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 306000000.00
CTVA income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 644000000.00
CTVA income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 159000000.00
CTVA income_statement (annual, 2025-12-31) — Diluted Average Shares: 681400000.00
CTVA income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 674700000.00
CTVA income_statement (annual, 2025-12-31) — Diluted EPS: 1.60
CTVA income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.82
CTVA income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1094000000.00
CTVA income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -552000000.00
CTVA income_statement (annual, 2025-12-31) — EBIT: 1868000000.00
CTVA income_statement (quarterly, 2025-12-31) — EBIT: -484000000.00
CTVA income_statement (annual, 2025-12-31) — EBITDA: 3071000000.00
CTVA income_statement (quarterly, 2025-12-31) — EBITDA: -178000000.00
CTVA income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 13000000.00
CTVA income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 4000000.00
CTVA cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 84000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -1000000.00
CTVA balance_sheet (annual, 2025-12-31) — Employee Benefits: 2434000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 2434000000.00
CTVA cash_flow (annual, 2025-12-31) — End Cash Position: 4725000000.00
CTVA cash_flow (quarterly, 2025-12-31) — End Cash Position: 4725000000.00
CTVA cash_flow (annual, 2025-12-31) — Financing Cash Flow: -1644000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -2198000000.00
CTVA balance_sheet (annual, 2025-12-31) — Finished Goods: 2956000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Finished Goods: 2956000000.00
CTVA cash_flow (annual, 2025-12-31) — Free Cash Flow: 2815000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 4153000000.00
CTVA cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -41000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -24000000.00
CTVA income_statement (annual, 2025-12-31) — Gain On Sale Of Business: 41000000.00
CTVA income_statement (quarterly, 2025-12-31) — Gain On Sale Of Business: 24000000.00
CTVA income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -181000000.00
CTVA income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -84000000.00
CTVA balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2797000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2797000000.00
CTVA balance_sheet (annual, 2025-12-31) — Goodwill: 10465000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Goodwill: 10465000000.00
CTVA balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 18766000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 18766000000.00
CTVA balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 5275000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 5275000000.00
CTVA balance_sheet (annual, 2025-12-31) — Gross PPE: 9551000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Gross PPE: 9551000000.00
CTVA income_statement (annual, 2025-12-31) — Gross Profit: 8229000000.00
CTVA income_statement (quarterly, 2025-12-31) — Gross Profit: 1656000000.00
CTVA cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 750000000.00
CTVA balance_sheet (annual, 2025-12-31) — Income Tax Payable: 155000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 155000000.00
CTVA income_statement (annual, 2025-12-31) — Interest Expense: 180000000.00
CTVA income_statement (quarterly, 2025-12-31) — Interest Expense: 46000000.00
CTVA income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 180000000.00
CTVA income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 46000000.00
CTVA income_statement (annual, 2025-12-31) — Interest Income: 136000000.00
CTVA income_statement (quarterly, 2025-12-31) — Interest Income: 44000000.00
CTVA income_statement (annual, 2025-12-31) — Interest Income Non Operating: 136000000.00
CTVA income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 44000000.00
CTVA cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 191000000.00
CTVA balance_sheet (annual, 2025-12-31) — Inventory: 5667000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Inventory: 5667000000.00
CTVA balance_sheet (annual, 2025-12-31) — Invested Capital: 26724000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Invested Capital: 26724000000.00
CTVA cash_flow (annual, 2025-12-31) — Investing Cash Flow: -543000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -188000000.00
CTVA balance_sheet (annual, 2025-12-31) — Investments And Advances: 160000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 160000000.00
CTVA cash_flow (annual, 2025-12-31) — Issuance Of Debt: 1730000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 87000000.00
CTVA balance_sheet (annual, 2025-12-31) — Land And Improvements: 449000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 449000000.00
CTVA balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 0.00
CTVA balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 0.00
CTVA balance_sheet (annual, 2025-12-31) — Long Term Debt: 1686000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1686000000.00
CTVA balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1686000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1686000000.00
CTVA cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 1730000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 87000000.00
CTVA cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -1871000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -755000000.00
CTVA balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 160000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 160000000.00
CTVA balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 6849000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 6849000000.00
CTVA balance_sheet (annual, 2025-12-31) — Minority Interest: 242000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Minority Interest: 242000000.00
CTVA income_statement (annual, 2025-12-31) — Minority Interests: -11000000.00
CTVA income_statement (quarterly, 2025-12-31) — Minority Interests: -3000000.00
CTVA cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -20000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -13000000.00
CTVA cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -1071000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -301000000.00
CTVA income_statement (annual, 2025-12-31) — Net Income: 1094000000.00
CTVA income_statement (quarterly, 2025-12-31) — Net Income: -552000000.00
CTVA income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 1094000000.00
CTVA income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -552000000.00
CTVA income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 1204000000.00
CTVA income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -537000000.00
CTVA income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: -99000000.00
CTVA income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: -12000000.00
CTVA income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1094000000.00
CTVA income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -552000000.00
CTVA income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1193000000.00
CTVA income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -540000000.00
CTVA cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 1204000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -537000000.00
CTVA income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 1105000000.00
CTVA income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -549000000.00
CTVA income_statement (annual, 2025-12-31) — Net Interest Income: -44000000.00
CTVA income_statement (quarterly, 2025-12-31) — Net Interest Income: -2000000.00
CTVA cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 52000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 40000000.00
CTVA cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -141000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -1787000000.00
CTVA cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -141000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -668000000.00
CTVA income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -44000000.00
CTVA income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -2000000.00
CTVA cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -45000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -2000000.00
CTVA cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -38000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -21000000.00
CTVA balance_sheet (annual, 2025-12-31) — Net PPE: 4220000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Net PPE: 4220000000.00
CTVA cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 54000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 28000000.00
CTVA cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
CTVA cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -1119000000.00
CTVA balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 5378000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 5378000000.00
CTVA balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 320000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 320000000.00
CTVA balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 251000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 251000000.00
CTVA balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 320000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 320000000.00
CTVA balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 251000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 251000000.00
CTVA balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2434000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2434000000.00
CTVA income_statement (annual, 2025-12-31) — Normalized EBITDA: 3392000000.00
CTVA income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -75000000.00
CTVA income_statement (annual, 2025-12-31) — Normalized Income: 1421959715.64
CTVA income_statement (quarterly, 2025-12-31) — Normalized Income: -458630000.00
CTVA cash_flow (annual, 2025-12-31) — Operating Cash Flow: 3406000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 4375000000.00
CTVA cash_flow (annual, 2025-12-31) — Operating Gains Losses: -5000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -15000000.00
CTVA income_statement (annual, 2025-12-31) — Operating Income: 2619000000.00
CTVA income_statement (quarterly, 2025-12-31) — Operating Income: 242000000.00
CTVA income_statement (annual, 2025-12-31) — Operating Revenue: 17401000000.00
CTVA income_statement (quarterly, 2025-12-31) — Operating Revenue: 3910000000.00
CTVA balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 672163000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 672163000.00
CTVA balance_sheet (annual, 2025-12-31) — Other Current Assets: 767000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 767000000.00
CTVA balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 894000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 894000000.00
CTVA balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -2797000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -2797000000.00
CTVA income_statement (annual, 2025-12-31) — Other Income Expense: -887000000.00
CTVA income_statement (quarterly, 2025-12-31) — Other Income Expense: -770000000.00
CTVA balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 8301000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 8301000000.00
CTVA cash_flow (annual, 2025-12-31) — Other Non Cash Items: 555000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 148000000.00
CTVA balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 2044000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 2044000000.00
CTVA balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 1963000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 1963000000.00
CTVA income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -579000000.00
CTVA income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -671000000.00
CTVA balance_sheet (annual, 2025-12-31) — Other Receivables: 1337000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Other Receivables: 1337000000.00
CTVA balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 9000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 9000000.00
CTVA balance_sheet (annual, 2025-12-31) — Payables: 4553000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Payables: 4553000000.00
CTVA balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 7652000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 7652000000.00
CTVA cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: 36000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Pension And Employee Benefit Expense: 9000000.00
CTVA income_statement (annual, 2025-12-31) — Pretax Income: 1688000000.00
CTVA income_statement (quarterly, 2025-12-31) — Pretax Income: -530000000.00
CTVA cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 88000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 13000000.00
CTVA balance_sheet (annual, 2025-12-31) — Properties: 0.00
CTVA balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CTVA cash_flow (annual, 2025-12-31) — Purchase Of Business: -20000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -13000000.00
CTVA cash_flow (annual, 2025-12-31) — Purchase Of Investment: -83000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -27000000.00
CTVA balance_sheet (annual, 2025-12-31) — Raw Materials: 435000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Raw Materials: 435000000.00
CTVA balance_sheet (annual, 2025-12-31) — Receivables: 6371000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Receivables: 6371000000.00
CTVA income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 8613000000.00
CTVA income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2107000000.00
CTVA income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1203000000.00
CTVA income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 306000000.00
CTVA cash_flow (annual, 2025-12-31) — Repayment Of Debt: -1871000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -755000000.00
CTVA cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -1071000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -301000000.00
CTVA income_statement (annual, 2025-12-31) — Research And Development: 1474000000.00
CTVA income_statement (quarterly, 2025-12-31) — Research And Development: 413000000.00
CTVA income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 181000000.00
CTVA income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 43000000.00
CTVA balance_sheet (annual, 2025-12-31) — Retained Earnings: -67000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -67000000.00
CTVA cash_flow (annual, 2025-12-31) — Sale Of Investment: 135000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 67000000.00
CTVA cash_flow (annual, 2025-12-31) — Sale Of PPE: 54000000.00
CTVA cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 28000000.00
CTVA income_statement (annual, 2025-12-31) — Selling General And Administration: 3492000000.00
CTVA income_statement (quarterly, 2025-12-31) — Selling General And Administration: 842000000.00
CTVA balance_sheet (annual, 2025-12-31) — Share Issued: 672163000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Share Issued: 672163000.00
CTVA income_statement (annual, 2025-12-31) — Special Income Charges: -140000000.00
CTVA income_statement (quarterly, 2025-12-31) — Special Income Charges: -19000000.00
CTVA balance_sheet (annual, 2025-12-31) — Stockholders Equity: 24144000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 24144000000.00
CTVA balance_sheet (annual, 2025-12-31) — Tangible Book Value: 5378000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 5378000000.00
CTVA income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -92040284.36
CTVA income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -21630000.00
CTVA income_statement (annual, 2025-12-31) — Tax Provision: 484000000.00
CTVA income_statement (quarterly, 2025-12-31) — Tax Provision: 7000000.00
CTVA income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.29
CTVA income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
CTVA balance_sheet (annual, 2025-12-31) — Total Assets: 42845000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Total Assets: 42845000000.00
CTVA balance_sheet (annual, 2025-12-31) — Total Capitalization: 25830000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 25830000000.00
CTVA balance_sheet (annual, 2025-12-31) — Total Debt: 2580000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Total Debt: 2580000000.00
CTVA balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 24386000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 24386000000.00
CTVA income_statement (annual, 2025-12-31) — Total Expenses: 14782000000.00
CTVA income_statement (quarterly, 2025-12-31) — Total Expenses: 3668000000.00
CTVA balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 18459000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 18459000000.00
CTVA balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 25510000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 25510000000.00
CTVA balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6334000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6334000000.00
CTVA balance_sheet (annual, 2025-12-31) — Total Tax Payable: 155000000.00
CTVA balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 155000000.00
CTVA income_statement (annual, 2025-12-31) — Total Unusual Items: -321000000.00
CTVA income_statement (quarterly, 2025-12-31) — Total Unusual Items: -103000000.00